Spontaneous Regression of Colonic Lymphoma Following Infliximab and Azathioprine Withdrawal in Patients With Crohn’s Disease
Authors:
- Ann D. FlynnAFAnn D. Flynn
- Jose M. AzarJAJose M. Azar
- Michael V. ChioreanMCMichael V. Chiorean
- 1 April 2013
- journal article
- Published by Oxford University Press (OUP) in Inflammatory Bowel Diseases
- Vol. 19 (5) , E69-E70
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Regression of Hodgkin Lymphoma After Discontinuation of a Tumor Necrosis Factor Inhibitor for Crohn's Disease: A Case Report and Review of the LiteratureClinical Lymphoma Myeloma and Leukemia, 2011
- Regression of lymphoma after withdrawal of infliximab alone in an infliximab/methotrexate-treated RA patientRheumatology, 2010
- Risk of Lymphoma Associated With Combination Anti–Tumor Necrosis Factor and Immunomodulator Therapy for the Treatment of Crohn's Disease: A Meta-AnalysisClinical Gastroenterology and Hepatology, 2009
- Reversible infliximab-related lymphoproliferative disorder associated with Epstein-Barr virus in a patient with rheumatoid arthritisModern Rheumatology, 2008
- Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: Relationship with type of latent Epstein‐Barr virus infectionAmerican Journal of Hematology, 2007
- Spontaneous regression of EBV-associated diffuse lymphoproliferative disease in a patient with rheumatoid arthritis after discontinuation of etanercept treatmentRheumatology International, 2007
- Spontaneous remission of marginal zone B cell lymphoma in a patient with seropositive rheumatoid arthritis after discontinuation of infliximab-methotrexate treatmentAnnals of the Rheumatic Diseases, 2005
- Reversible Lymphomas Associated with Epstein-Barr Virus Occurring during Methotrexate Therapy for Rheumatoid Arthritis and DermatomyositisNew England Journal of Medicine, 1993